DNLI - Denali Therapeutics GAAP EPS of -$0.78 misses by $0.09
2025-05-06 17:05:00 ET
More on Denali Therapeutics
- Denali Therapeutics: Vast Pipeline, First Approval Up Ahead
- Denali Therapeutics closes down 11% as 2025 operating expenses seen weighing
- Seeking Alpha’s Quant Rating on Denali Therapeutics
- Historical earnings data for Denali Therapeutics
- Financial information for Denali Therapeutics